Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · NPW

Percutaneously Delivered Prostheses And Tricuspid Valves

These devices are intended to replace a patient's tricuspid heart valve. They are different from the classified device (heart valves) in that they are placed percutaniously and do not require open chest surgery or a cardiotomy for placement.

Product / regulatory recordCompanyPathwayDecision dateSource
Edwards Lifesciences, LLCPMA supplementOct 28, 2026FDA
Edwards Lifesciences, LLCPMA supplementOct 21, 2026FDA
Edwards Lifesciences, LLCPMA supplementOct 19, 2026FDA
Edwards Lifesciences, LLCPMA supplementSep 16, 2026FDA
Edwards Lifesciences, LLCPMA supplementAug 5, 2026FDA
Edwards Lifesciences, LLCPMA supplementJul 29, 2026FDA
Edwards Lifesciences, LLCPMA supplementMay 26, 2026FDA
Edwards Lifesciences, LLCPMA supplementApr 29, 2026FDA
Edwards Lifesciences, LLCPMA supplementApr 16, 2026FDA
Edwards Lifesciences, LLCPMA supplementApr 10, 2026FDA
Edwards Lifesciences, LLCPMA supplementMar 11, 2026FDA
Edwards Lifesciences, LLCPMA supplementFeb 12, 2026FDA
Edwards Lifesciences, LLCPMA supplementFeb 11, 2026FDA
Edwards Lifesciences, LLCPMA supplementFeb 2, 2026FDA
Edwards Lifesciences, LLCPMA supplementNov 19, 2025FDA
Edwards Lifesciences, LLCPMA supplementOct 31, 2025FDA
Edwards Lifesciences, LLCPMA supplementSep 25, 2025FDA
Edwards Lifesciences, LLCPMA supplementSep 12, 2025FDA
Edwards Lifesciences, LLCPMA supplementAug 13, 2025FDA
Edwards Lifesciences, LLCPMA supplementJul 23, 2025FDA
Edwards Lifesciences, LLCPMA approvalFeb 1, 2024FDA
Source information

Follow the FDA links to view the original records.

All device categories